ConductScience.org, home

Paper30450666

Recent clinical trends in Toll-like receptor targeting therapeutics.

Anwar MA and 3 others. Med Res Rev, 2019. Cited by 230 papers, by iCite.

Cite this record

ConductScience Library. Recent clinical trends in Toll-like receptor targeting therapeutics. Papers, record 30450666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30450666

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent clinical trends in Toll-like receptor targeting therapeutics.
PubMed
Journal
Med Res Rev
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
230
iCite
Relative citation ratio, by iCite
9.48
iCite
Revised in PubMed
2021-01-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anwar MAMuhammad Ayaz
2Shah MMasaud
3Kim JJason
4Choi SSangdunhttps://orcid.org/0000-0001-5920-7848

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Molecular Targeted TherapyMajor topic
Toll-Like ReceptorsMajor topic
Adjuvants, Immunologic
Animals
Clinical Trials as Topic
Disease
Humans
Ligands
Signal Transduction

Source PubMed

Download CSV of topics

References170

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127742543Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.Immunity2016https://conductscience.org/library/papers/27742543PubMed
222444240Regulation of B-cell responses by Toll-like receptors.Immunology2012https://conductscience.org/library/papers/22444240PubMed
311037875Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines.Arthritis Rheum2000https://conductscience.org/library/papers/11037875PubMed
423934186The Yin and Yang of Toll-like receptors in cancer.Oncogene2014https://conductscience.org/library/papers/23934186PubMed
518701762The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.Oncologist2008https://conductscience.org/library/papers/18701762PubMed
625093709Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients.Allergy2014https://conductscience.org/library/papers/25093709PubMed
721674704Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.Inflamm Bowel Dis2011https://conductscience.org/library/papers/21674704PubMed
819944565Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.J Autoimmun2010https://conductscience.org/library/papers/19944565PubMed
922142805Inpatient care for septicemia or sepsis: a challenge for patients and hospitals.NCHS Data Brief2011https://conductscience.org/library/papers/22142805PubMed
1025667264Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.Infect Immun2015https://conductscience.org/library/papers/25667264PubMed
1127612280RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.Cancer Treat Rev2016https://conductscience.org/library/papers/27612280PubMed
1215001781A toll-like receptor that prevents infection by uropathogenic bacteria.Science2004https://conductscience.org/library/papers/15001781PubMed
1324894651
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Invest New Drugs2014https://conductscience.org/library/papers/24894651PubMed
1419917698TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients.J Immunol2009https://conductscience.org/library/papers/19917698PubMed
1522521140Adjuvants for human vaccines.Curr Opin Immunol2012https://conductscience.org/library/papers/22521140PubMed
169875924Has the mortality of septic shock changed with time.Crit Care Med1998https://conductscience.org/library/papers/9875924PubMed
1718199559Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.Cancer Res2008https://conductscience.org/library/papers/18199559PubMed
1810215628TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.Genes Dev1999https://conductscience.org/library/papers/10215628PubMed
1916260493TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.Genes Dev2005https://conductscience.org/library/papers/16260493PubMed
2018029230Signaling to NF-kappaB by Toll-like receptors.Trends Mol Med2007https://conductscience.org/library/papers/18029230PubMed

See all 170 referencesDownload CSV of references

Cited by151

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.

PMIDTitleJournalYearIn PapersSource
42327785Toll-like receptors: versatile players in tumor.Front Immunol2026https://conductscience.org/library/papers/42327785PubMed
42213280TLR ligands as immunomodulators: mechanistic insights and therapeutic potential in infectious and inflammatory diseases.Mol Biol Rep2026https://conductscience.org/library/papers/42213280PubMed
41793185Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41793185PubMed
41787453Neutrophil extracellular traps-associated candidate genes in IgA vasculitis: an exploratory multi-omics analysis integrating transcriptomics and Mendelian randomization.Pediatr Rheumatol Online J2026https://conductscience.org/library/papers/41787453PubMed
41706189Immunoinformatics-guided design of a multi-epitope vaccine targeting the envelopment polyprotein of oropouche virus.Mol Genet Genomics2026https://conductscience.org/library/papers/41706189PubMed
41597427Toll-like Receptor 7/8 Agonists Exert Antitumor Effect in a Mouse Melanoma Model.Medicina (Kaunas)2026https://conductscience.org/library/papers/41597427PubMed
41417465Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives.J Med Chem2026https://conductscience.org/library/papers/41417465PubMed
41322409Extracellular microRNAs modulate human microglial function through TLR8.Front Immunol2025https://conductscience.org/library/papers/41322409PubMed
41158497Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population.ERJ Open Res2025https://conductscience.org/library/papers/41158497PubMed
40891672Toll-like receptors (TLRs) in the trained immunity era.Elife2025https://conductscience.org/library/papers/40891672PubMed
40837119Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines.Nano Res2025https://conductscience.org/library/papers/40837119PubMed
40573201Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate Cancer.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40573201PubMed
40396589Exploring the Role of Pattern Recognition Receptors as Immunostimulatory Molecules.Immun Inflamm Dis2025https://conductscience.org/library/papers/40396589PubMed
40163200Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment.Med Oncol2025https://conductscience.org/library/papers/40163200PubMed
39982077Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.Clin Microbiol Rev2025https://conductscience.org/library/papers/39982077PubMed
39947253The Recruitment and Immune Suppression Mechanisms of Myeloid-Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/39947253PubMed
39827246TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity.NPJ Vaccines2025https://conductscience.org/library/papers/39827246PubMed
39769150Novel Peptidomimetic Cyclo-{E(I)-E(W)}Na (CP-88) with Hematopoietic Activity Sustained in Invasive and Oral Administration: Experimental and Preclinical Evaluation.Int J Mol Sci2024https://conductscience.org/library/papers/39769150PubMed
39684260Senescent T Cells: The Silent Culprit in Acute Myeloid Leukemia Progression?Int J Mol Sci2024https://conductscience.org/library/papers/39684260PubMed
39655168Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacology.ERJ Open Res2024https://conductscience.org/library/papers/39655168PubMed

See all 151 cited byDownload CSV of cited by

Genes86

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
ATF3467PubTator's text mininghttps://conductscience.org/library/genes/467NCBI Gene
BCL3602PubTator's text mininghttps://conductscience.org/library/genes/602NCBI Gene
BMPR2659PubTator's text mininghttps://conductscience.org/library/genes/659NCBI Gene
CBLB868PubTator's text mininghttps://conductscience.org/library/genes/868NCBI Gene
CCL36348PubTator's text mininghttps://conductscience.org/library/genes/6348NCBI Gene
CCL56352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CHUK1147PubTator's text mininghttps://conductscience.org/library/genes/1147NCBI Gene
CISH1154PubTator's text mininghttps://conductscience.org/library/genes/1154NCBI Gene
CXCL116373PubTator's text mininghttps://conductscience.org/library/genes/6373NCBI Gene
DPP41803PubTator's text mininghttps://conductscience.org/library/genes/1803NCBI Gene
FABP9646480PubTator's text mininghttps://conductscience.org/library/genes/646480NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

See all 86 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30450666

GET https://conductscience.org/api/papers/v1/30450666/references?page=2